{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:52:13Z","timestamp":1776207133182,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,14]]},"DOI":"10.7759\/cureus.107058","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:03:36Z","timestamp":1776204216000},"source":"Crossref","is-referenced-by-count":0,"title":["Neonatal Hyperinsulinemia and Maternal Diabetes Associated With a Hepatocyte Nuclear Factor 4 Alpha (HNF4A) Variant"],"prefix":"10.7759","author":[{"given":"Yuki","family":"Takasugi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Takasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112910","article-title":"Insights into the genetics and signaling pathways in maturity-onset diabetes of the young","volume":"23","author":"Sousa M","year":"2022","unstructured":"Sousa M, Rego T, Armas JB. Insights into the genetics and signaling pathways in maturity-onset diabetes of the young. Int J Mol Sci. 2022, 23:12910. 10.3390\/ijms232112910","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1497298","article-title":"Current views on etiology, diagnosis, epidemiology and gene therapy of maturity onset diabetes in the young","volume":"15","author":"Dzhemileva LU","year":"2025","unstructured":"Dzhemileva LU, Zakharova EN, Goncharenko AO, et al.. Current views on etiology, diagnosis, epidemiology and gene therapy of maturity onset diabetes in the young. Front Endocrinol. 2025, 15:1497298. 10.3389\/fendo.2024.1497298","journal-title":"Front Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1226173","article-title":"HNF4\u03b1 isoforms: the fraternal twin master regulators of liver function","volume":"14","author":"Radi SH","year":"2023","unstructured":"Radi SH, Vemuri K, Martinez-Lomeli J, Sladek FM. HNF4\u03b1 isoforms: the fraternal twin master regulators of liver function. Front Endocrinol. 2023, 14:1226173. 10.3389\/fendo.2023.1226173","journal-title":"Front Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-022-09749-2","article-title":"Variable phenotypes of individual and family monogenic cases with hyperinsulinism and diabetes: a systematic review","volume":"23","author":"Perge K","year":"2022","unstructured":"Perge K, Nicolino M. Variable phenotypes of individual and family monogenic cases with hyperinsulinism and diabetes: a systematic review. Rev Endocr Metab Disord. 2022, 23:1063-78. 10.1007\/s11154-022-09749-2","journal-title":"Rev Endocr Metab Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei IA","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, et al.. A method and server for predicting damaging missense mutations. Nat Methods. 2010, 7:248-9. 10.1038\/nmeth0410-248","journal-title":"Nat Methods"},{"key":"ref6","unstructured":"HegeLab. AlphaMissense: description. (2024). Accessed: April 9, 2026: https:\/\/alphamissense.hegelab.org\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher M","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014, 46:310-5. 10.1038\/ng.2892","journal-title":"Nat Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards S","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015, 17:405-24. 10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.00320","article-title":"A novel HNF4A mutation causing three phenotypic forms of glucose dysregulation in a family","volume":"8","author":"Chandran S","year":"2020","unstructured":"Chandran S, Rajadurai VS, Hoi WH, Flanagan SE, Hussain K, Yap F. A novel HNF4A mutation causing three phenotypic forms of glucose dysregulation in a family. Front Pediatr. 2020, 8:320. 10.3389\/fped.2020.00320","journal-title":"Front Pediatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1657","article-title":"Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations","volume":"57","author":"Kapoor RR","year":"2008","unstructured":"Kapoor RR, Locke J, Colclough K, et al.. Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations. Diabetes. 2008, 57:1659-63. 10.2337\/db07-1657","journal-title":"Diabetes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0755","article-title":"ATP-sensitive potassium channels in hyperinsulinism and type 2 diabetes: inconvenient paradox or new paradigm?","volume":"71","author":"Nichols CG","year":"2022","unstructured":"Nichols CG, York NW, Remedi MS. ATP-sensitive potassium channels in hyperinsulinism and type 2 diabetes: inconvenient paradox or new paradigm?. Diabetes. 2022, 71:367-75. 10.2337\/db21-0755","journal-title":"Diabetes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0897","article-title":"Clinical and genetic heterogeneity of HNF4A\/HNF1A mutations in a multicentre paediatric cohort with hyperinsulinaemic hypoglycaemia","volume":"186","author":"McGlacken-Byrne SM","year":"2022","unstructured":"McGlacken-Byrne SM, Mohammad JK, Conlon N, et al.. Clinical and genetic heterogeneity of HNF4A\/HNF1A mutations in a multicentre paediatric cohort with hyperinsulinaemic hypoglycaemia. Eur J Endocrinol. 2022, 186:417-27. 10.1530\/EJE-21-0897","journal-title":"Eur J Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-19-0013","article-title":"Exceptional diazoxide sensitivity in hyperinsulinaemic hypoglycaemia due to a novel HNF4A mutation","volume":"2019","author":"Arya VB","year":"2019","unstructured":"Arya VB, Kalitsi J, Hickey A, Flanagan SE, Kapoor RR. Exceptional diazoxide sensitivity in hyperinsulinaemic hypoglycaemia due to a novel HNF4A mutation. Endocrinol Diabetes Metab Case Rep. 2019, 2019:10.1530\/EDM-19-0013","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13426","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: the diagnosis and management of monogenic diabetes in children and adolescents","volume":"23","author":"Greeley SA","year":"2022","unstructured":"Greeley SA, Polak M, Nj\u00f8lstad PR, et al.. ISPAD Clinical Practice Consensus Guidelines 2022: the diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2022, 23:1188-211. 10.1111\/pedi.13426","journal-title":"Pediatr Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/a-2436-7723","article-title":"Novel treatment options in patients with maturity-onset diabetes of the young","volume":"133","author":"M\u00fcssig K","year":"2025","unstructured":"M\u00fcssig K. Novel treatment options in patients with maturity-onset diabetes of the young. Exp Clin Endocrinol Diabetes. 2025, 133:51-8. 10.1055\/a-2436-7723","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/479266-neonatal-hyperinsulinemia-and-maternal-diabetes-associated-with-a-hepatocyte-nuclear-factor-4-alpha-hnf4a-variant","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:03:37Z","timestamp":1776204217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/479266-neonatal-hyperinsulinemia-and-maternal-diabetes-associated-with-a-hepatocyte-nuclear-factor-4-alpha-hnf4a-variant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.107058","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}